Showing results (91-100 of 111) with videos related to
Sort By:
Pageof 12
Breast Cancer Research : BCR|July 19, 2006
Central nervous system relapse in patients with breast cancer is associated with advanced stages, with the presence of circulating occult tumor cells and with the HER2/neu statusJohn Souglakos, Lambros Vamvakas, Stella Apostolaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2010
Prognostic significance of the detection of peripheral blood CEACAM5mRNA-positive cells by real-time polymerase chain reaction in operable colorectal cancerNikolaos Vardakis, Ippokratis Messaritakis, Chara Papadaki, et al.The Lancet. Oncology|February 3, 2019
Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisEverardo D Saad, Pierre Squifflet, Tomasz Burzykowski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2007
Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancerMichail Ignatiadis, Nikos Xenidis, Maria Perraki, et al.Plos One|February 10, 2023
Effect of body tissue composition on the outcome of patients with metastatic non-small cell lung cancer treated with PD-1/PD-L1 inhibitorsDimitrios Makrakis, Konstantinos Rounis, Alexandros-Pantelis Tsigkas, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptideIrini Bolonaki, Athanassios Kotsakis, Elsa Papadimitraki, et al.Plos One|November 13, 2008
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patientsIoannis Boukovinas, Chara Papadaki, Pedro Mendez, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 13, 2011
Sequential administration of the native TERT572 cryptic peptide enhances the immune response initiated by its optimized variant TERT(572Y) in cancer patientsEleni-Kyriaki Vetsika, Elisavet Papadimitraki, Despoina Aggouraki, et al.BMC Cancer|June 1, 2007
Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II studyChristos Emmanouilides, Georgia Sfakiotaki, Nikolaos Androulakis, et al.Lung Cancer (Amsterdam, Netherlands)|September 4, 2007
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trialVassilis Georgoulias, Nikolaos Androulakis, Athanasios Kotsakis, et al.Pageof 12